naltrexone has been researched along with pituitrin in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (50.00) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croiset, G; de Rotte, GA; Goedemans, HJ; Thody, TJ; van Ree, JM; van Wimersma Greidanus, TB; Verspaget, H | 1 |
| Armstrong, WE; Crowley, WR; Grosvenor, CE; Parker, SL; Wang, W | 1 |
| Koehler, E; McLemore, GL; Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Kraft, K; Vetter, H | 1 |
| Fleshner, M; Thurston, CL; Watkins, LR | 1 |
| Emmert, SE; Hartman, RD; Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Rosella-Dampman, LM; Summy-Long, JY | 1 |
| Atkinson, RL | 1 |
| Ludens, JH; Slizgi, GR | 1 |
| Bakharev, VD; Tikhomirov, SM | 1 |
| Berkowitz, BA; Sherman, S | 1 |
| Deen, K; Keil, LC; Severs, WB; Summy-Long, JY | 1 |
| Brown, CH; Leng, G; Ludwig, M | 2 |
| Bourque, CW; Brown, CH; Leng, G; Ludwig, M | 1 |
| Bishop, VR; Brown, CH; Leng, G; Scott, V | 1 |
2 review(s) available for naltrexone and pituitrin
| Article | Year |
|---|---|
Endocrine and metabolic effects of opiate antagonists.
Topics: Adrenocorticotropic Hormone; Animals; Body Weight; Eating; Endocrine Glands; Female; Follicle Stimulating Hormone; Hormones; Humans; Hydrocortisone; Luteinizing Hormone; Male; Mice; Naloxone; Naltrexone; Rats; Vasopressins | 1984 |
[Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases].
Topics: Animals; Anticonvulsants; Antipsychotic Agents; Depressive Disorder; Drug Therapy, Combination; Endorphins; Enkephalins; Humans; Mental Disorders; Naloxone; Naltrexone; Nerve Tissue Proteins; Pituitary Hormones; Psychotropic Drugs; Schizophrenia; Substance-Related Disorders; Vasopressins | 1984 |
14 other study(ies) available for naltrexone and pituitrin
| Article | Year |
|---|---|
Effects of morphine and beta-endorphin on basal and elevated plasma levels of alpha-MSH and vasopressin.
Topics: Animals; Endorphins; Injections, Intraperitoneal; Injections, Intraventricular; Male; Melanocyte-Stimulating Hormones; Morphine; Naltrexone; Rats; Vasopressins | 1979 |
Excitatory and inhibitory dopaminergic regulation of oxytocin secretion in the lactating rat: evidence for respective mediation by D-1 and D-2 dopamine receptor subtypes.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Bromocriptine; Domperidone; Dopamine; Dopamine Antagonists; Electric Stimulation; Female; Lactation; Naltrexone; Oxytocin; Pituitary Gland; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Vasopressins | 1991 |
Kappa opiate receptors inhibit release of oxytocin from the magnocellular system during dehydration.
Topics: Animals; Benzomorphans; Dehydration; Dynorphins; Endorphins; Hypertonic Solutions; Injections, Intraventricular; Male; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Osmolar Concentration; Oxytocin; Peptide Fragments; Pituitary Gland, Posterior; Protein Precursors; Radioimmunoassay; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Vasopressins | 1990 |
Long-term opiate receptor antagonism in a patient with panhypopituitarism: effects on appetite, prolactin and demand for vasopressin.
Topics: Adult; Appetite; Drug Administration Schedule; Female; Humans; Hypopituitarism; Naltrexone; Obesity, Morbid; Prolactin; Vasopressins; Weight Loss | 1991 |
Phenylephrine-induced antinociception: investigations of potential neural and endocrine bases.
Topics: Adrenal Glands; Analgesics; Animals; Arginine Vasopressin; Blood Pressure; Corticosterone; Dexamethasone; Endocrine Glands; Heart Rate; Male; Monitoring, Physiologic; Naloxone; Naltrexone; Neural Pathways; Phenylephrine; Rats; Rats, Inbred Strains; Spinal Cord; Vasopressins | 1990 |
Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
Topics: Animals; Dehydration; Endorphins; Hypertonic Solutions; Hypothalamus; Male; Naltrexone; Osmosis; Oxytocin; Pituitary Gland, Posterior; Rats; Rats, Inbred Strains; Sodium Chloride; Vasopressins | 1986 |
Dexamethasone differentially alters naltrexone effects on vasopressin and oxytocin release during tail electroshock.
Topics: Animals; Body Weight; Dexamethasone; Electroshock; Hematocrit; Male; Naltrexone; Oxytocin; Pituitary Gland; Rats; Rats, Inbred Strains; Tail; Time Factors; Vasopressins | 1985 |
Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine.
Topics: Analgesics, Opioid; Animals; Body Water; Bufo marinus; Cyclazocine; Diuretics; Dose-Response Relationship, Drug; Ethylketocyclazocine; Male; Naltrexone; Radioimmunoassay; Rats; Rats, Inbred Strains; Urinary Bladder; Vasopressins | 1982 |
Characterization of vasopressin analgesia.
Topics: Analgesics; Animals; Arginine Vasopressin; Blood Pressure; Injections, Intraventricular; Male; Mice; Motor Activity; Naltrexone; Rats; Rats, Inbred Strains; Vasopressins | 1982 |
Opiate regulation of angiotensin-induced drinking and vasopressin release.
Topics: Angiotensin II; Animals; Drinking; Endorphins; Enkephalin, Leucine; Enkephalins; Male; Naloxone; Naltrexone; Rats; Saralasin; Vasopressins | 1981 |
kappa-opioid regulation of neuronal activity in the rat supraoptic nucleus in vivo.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Cells, Cultured; Dendrites; Down-Regulation; Dynorphins; Electrophysiology; Female; Injections, Intravenous; Membrane Potentials; Microdialysis; Naloxone; Naltrexone; Narcotic Antagonists; Neurons; Oxytocin; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Supraoptic Nucleus; Vasopressins | 1998 |
Temporal dissociation of the feedback effects of dendritically co-released peptides on rhythmogenesis in vasopressin cells.
Topics: Action Potentials; Animals; Antidiuretic Hormone Receptor Antagonists; Dendrites; Dynorphins; Feedback, Physiological; Female; Naltrexone; Narcotic Antagonists; Periodicity; Piperidines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Supraoptic Nucleus; Vasopressins | 2004 |
Endogenous activation of supraoptic nucleus kappa-opioid receptors terminates spontaneous phasic bursts in rat magnocellular neurosecretory cells.
Topics: Action Potentials; Animals; Electric Stimulation; In Vitro Techniques; Male; Naltrexone; Narcotic Antagonists; Neurons; Rats; Rats, Long-Evans; Receptors, Opioid, kappa; Statistics, Nonparametric; Supraoptic Nucleus; Time Factors; Vasopressins | 2006 |
Dehydration-induced modulation of kappa-opioid inhibition of vasopressin neurone activity.
Topics: Action Potentials; Animals; Cholecystokinin; Dehydration; Electrophysiology; Enkephalins; Female; Hypernatremia; Hyponatremia; Immunohistochemistry; In Situ Hybridization; Naltrexone; Narcotic Antagonists; Neurons; Oxytocin; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; RNA, Messenger; Vasopressins | 2009 |